The stock market fell sharply anew on Wednesday, with all major indices ending in the red, as investor sentiment was dampened ...

Fans thought the tennis legend was dissing her ex Drake by appearing during 'Not Like Us,' a song infamously about him.

Serena Williams is clearing the air about her Super Bowl halftime cameo. The tennis legend, who was named one of Time's 100 Most Influential People of 2025 on Wednesday, opened up to the outlet about ...

Since becoming the starting quarterback of the Eagles in 2021, Hurts has gone 45-17 as a starting quarterback and has been an ...

Happy birthday, Jonathan Vilma. The Super Bowl-winning linebacker wasn't in New Orleans as long as you may think, but he made every minute count.

Jefferies analyst Glen Santangelo raised the firm’s price target on Hims & Hers to $25 from $21 and keeps a Hold rating on the shares. A ...

Hims & Hers is expanding access to Eli Lilly's branded weight loss drug Zepbound and diabetes drug Mounjaro as well as ...

Eli Lilly quickly disassociated itself from Hims & Hers after the telehealth company said it was selling the pharmaceutical company’s weight-loss drug.

Hims & Hers Health shares jumped Tuesday as the company added Eli Lilly’s weight-loss drug Zepbound and diabetes treatment Mounjaro to its telehealth platform. The treatments will each cost $ ...

While there's still plenty of work to be done, Hims is one of many such companies that's helping to expand healthcare options, by opening the conversation around men's health, in particular.